Patents by Inventor Kerry Fowler

Kerry Fowler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11858889
    Abstract: Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: January 2, 2024
    Assignee: THE TRUSTEES OF INDIANA UNIVERSITY
    Inventors: Jaipal Singh, Kerry Fowler
  • Publication number: 20220144795
    Abstract: Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.
    Type: Application
    Filed: December 30, 2021
    Publication date: May 12, 2022
    Inventors: Jaipal SINGH, Kerry FOWLER
  • Patent number: 11267780
    Abstract: Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: March 8, 2022
    Assignee: The Trustees of Indiana University
    Inventors: Jaipal Singh, Kerry Fowler
  • Publication number: 20210009498
    Abstract: Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.
    Type: Application
    Filed: April 30, 2019
    Publication date: January 14, 2021
    Inventors: Jaipal SINGH, Kerry FOWLER
  • Publication number: 20070259863
    Abstract: The present invention relates in part to compounds of formulas I and III: and pharmaceutically-acceptable salts and prodrugs thereof. These compounds can be useful for treating diseases such as inflammatory and immune diseases. The present invention also relates to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a subject.
    Type: Application
    Filed: April 28, 2005
    Publication date: November 8, 2007
    Applicants: ICOS Corporation, Biogen Idec MA Inc.
    Inventors: Donovan Chin, Thomas Durand-Reville, Francine Farouz, Kerry Fowler, Kevin Guckian, Irina Jaconbson, Ramesh Kasar, Russell Petter, Daniel Scott, C. Gregory Sowell, Eugene Thorsett, Edward Yin-Shiang Lin
  • Publication number: 20060074123
    Abstract: Novel pyrrolidine compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
    Type: Application
    Filed: November 7, 2005
    Publication date: April 6, 2006
    Applicant: ICOS CORPORATION
    Inventors: Timothy Martins, Kerry Fowler, Joshua Odingo, Edward Kesicki, Amy Oliver, Laurence Burgess, John Gaudino, Zachary Jones, Bradley Newhouse, Stephen Schlachter